To observe the effect of vericiguat combined with dapagliflozin in patients with heart failure with reduced ejection fraction (HFrEF).
A total of 98 patients with HFrEF in our hospital from January 2023 to January 2024 were selected and divided into combination group and control group according to random number table method, with 49 cases in each group. On the basis of conventional HF treatment, the control group was given dapagliflozin, the combination group was given dapagliflozin combined with vericiguat. Both groups were treated for 6 months. The clinical effect, adverse reactions, HF rehospitalization rate and major adverse cardiovascular event (MACE) were compared between the two groups. The cardiac function indexes, N-terminal brain natriuretic peptide precursor (NT-proBNP), neutrophil-to-lymphocyte ratio (NLR), C-reactive protein (CRP), Minnesota living with heart failure questionnaire (MLHFQ) score, 6-minute walking test (6MWT) distance were compared between the two groups before and after treatment.
After treatment, the total effective rate of combination group was higher than that of control group (93.62% vs 70.83%, P<0.05). The LVEF level and 6MWT distance were increased in both groups, and the combination group was higher than the control group (P<0.05). The levels of LVEDD, LVESD, NT-proBNP, NLR, CRP and MLHFQ score were all decreased, and the combination group was lower than the control group (P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups (P<0.05). The incidence of HF rehospitalization (6.38% vs 20.83%, P<0.05) and MACE (12.77% vs 31.25%, P<0.05) in the combination group were lower than those in the control group, respectively.
Vericiguat combined with dapagliflozin can significantly reduce ventricular remodeling and inflammatory response in HFrEF patients, enhance efficacy, improve quality of life and prognosis, and have good safety.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |